NEW YORK, NY / / November 5, 2025 / Every generation reaches a point when progress demands proof. For Europe, following ...
Guest writer Dr Kun-Yu Wang describes how the development of a tunable MOF illustrates chemistry's potential in mechanical ...
Announced positive results from two pivotal Phase 3 Essential3 studies of ulixacaltamide HCl in essential tremor (ET); Pre-NDA meeting with FDA ...
Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and small molecule therapies for other ...
Scientists at Mizzou have identified two small molecules, agmatine and thiamine, that could both reveal and fight glaucoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback